Literature DB >> 18781953

Roles of NHERF1/EBP50 in cancer.

Maria-Magdalena Georgescu1, Fabiana C Morales, Jennifer R Molina, Yuho Hayashi.   

Abstract

This review summarizes the emerging roles of NHERF1/EBP50 adaptor protein in tumorigenesis. NHERF1/EBP50 (Na(+)/H(+) exchanger regulating factor 1; ezrin-radixin-moesin (ERM) binding phosphoprotein of 50 kDa) is a PDZ domain-containing protein with physiological localization at the plasma membrane. We discuss in this review the functions of NHERF1/EBP50 as a linker between membrane proteins and the cytoskeleton network, as well as its involvement in different types of cancer, such as breast and liver cancers. Recent evidence obtained from our laboratory and from other groups shows that NHERF1/EBP50 is an important player in cancer progression. It appears that, depending on its subcellular distribution, NHERF1/EBP50 may behave either as a tumor suppressor, when it is localized at the plasma membrane, or as an oncogenic protein, when it is shifted to the cytoplasm. We provide here an overview of the mechanisms by which this adaptor protein controls cell transformation, and propose a model suggesting a dual role of NHERF1/EBP50 in cancer.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18781953     DOI: 10.2174/156652408785748031

Source DB:  PubMed          Journal:  Curr Mol Med        ISSN: 1566-5240            Impact factor:   2.222


  55 in total

1.  Phosphorylation of EBP50 negatively regulates β-PIX-dependent Rac1 activity in anoikis.

Authors:  J-Y Chen; Y-Y Lin; T-S Jou
Journal:  Cell Death Differ       Date:  2012-02-03       Impact factor: 15.828

2.  Novel bioactivity of NHERF1 in corneal neovascularization.

Authors:  Peng Chen; Ye Wang; Lingling Yang; Changyou Li; Yao Wang; Lixin Xie; Yiqiang Wang
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2012-07-10       Impact factor: 3.117

3.  NHERF1/EBP50 in Breast Cancer: Clinical Perspectives.

Authors:  Antonia Bellizzi; Andrea Malfettone; Rosa A Cardone; Anita Mangia
Journal:  Breast Care (Basel)       Date:  2010-04-09       Impact factor: 2.860

Review 4.  New roles of the Na+/H+ exchange regulatory factor 1 scaffolding protein: a review.

Authors:  Adrienne M Bushau-Sprinkle; Eleanor D Lederer
Journal:  Am J Physiol Renal Physiol       Date:  2020-01-27

5.  Dynamic structure of the full-length scaffolding protein NHERF1 influences signaling complex assembly.

Authors:  Shibani Bhattacharya; Christopher B Stanley; William T Heller; Peter A Friedman; Zimei Bu
Journal:  J Biol Chem       Date:  2019-06-06       Impact factor: 5.157

6.  Loss of the Na+/H+ Exchange Regulatory Factor 1 Increases Susceptibility to Cisplatin-Induced Acute Kidney Injury.

Authors:  Adrienne Bushau-Sprinkle; Michelle Barati; Caryl Conklin; Tess Dupre; Kenneth B Gagnon; Syed J Khundmiri; Barbara Clark; Leah Siskind; Mark A Doll; Madhavi Rane; Michael Brier; Susan Coventry; Eleanor D Lederer
Journal:  Am J Pathol       Date:  2019-03-27       Impact factor: 4.307

7.  The detection of EBP50 expression using quantum dot immunohistochemistry in pancreatic cancer tissue and down-regulated EBP50 effect on PC-2 cells.

Authors:  Meng-Yao Ji; Di-kun Fan; Xiao-Guang Lv; Xiu-Lan Peng; Xiao-Fei Lei; Wei-Guo Dong
Journal:  J Mol Histol       Date:  2012-05-24       Impact factor: 2.611

8.  PTEN inhibits macrophage polarization from M1 to M2 through CCL2 and VEGF-A reduction and NHERF-1 synergism.

Authors:  Ning Li; Junfang Qin; Lan Lan; Hongyao Zhang; Fang Liu; Zhaozhen Wu; Hong Ni; Yue Wang
Journal:  Cancer Biol Ther       Date:  2015       Impact factor: 4.742

9.  Autoinhibitory interactions between the PDZ2 and C-terminal domains in the scaffolding protein NHERF1.

Authors:  Hong Cheng; Jianquan Li; Ruzaliya Fazlieva; Zhongping Dai; Zimei Bu; Heinrich Roder
Journal:  Structure       Date:  2009-05-13       Impact factor: 5.006

10.  PDZ domains and their binding partners: structure, specificity, and modification.

Authors:  Ho-Jin Lee; Jie J Zheng
Journal:  Cell Commun Signal       Date:  2010-05-28       Impact factor: 5.712

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.